Insider · CIK 0001553489
Bryan M. Reasons
Files at ACRS (Aclaris Therapeutics, Inc.), MNKTQ (Mallinckrodt plc), SCTL (Societal CDMO, Inc.). First filing -, latest -.
In brief
Bryan M. Reasons files SEC Form 4 as CFO and director at ACRS (Aclaris Therapeutics, Inc.), and also at MNKTQ (Mallinckrodt plc), SCTL (Societal CDMO, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Bryan M. Reasons has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 9 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 31, 2025 | MNKTQ Mallinckrodt plc | AGrant or award Restricted Stock Unitsderivative | +41,035 | $0.00 | $0 | 54,714 | Aug 4, 2025 |
| Jun 1, 2024 | ACRS Aclaris Therapeutics, Inc. | MOption exercise Common Stock | +4,660 | - | - | 28,732 | Jun 4, 2024 |
| Jun 1, 2024 | ACRS Aclaris Therapeutics, Inc. | MOption exercise Restricted Stock Unitsderivative | -4,660 | $0.00 | $0 | 0 | Jun 4, 2024 |
| Apr 8, 2024 | SCTL Societal CDMO, Inc. | UTender of shares Common Stock | -217,429 | $1.10 | $239k | 73,620 | Apr 8, 2024 |
| Apr 8, 2024 | SCTL Societal CDMO, Inc. | DDisposition to issuer Common Stock | -73,620 | $1.10 | $81k | 0 | Apr 8, 2024 |
| Apr 8, 2024 | SCTL Societal CDMO, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -118,182 | - | - | 0 | Apr 8, 2024 |
| Apr 8, 2024 | SCTL Societal CDMO, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -27,229 | - | - | 0 | Apr 8, 2024 |
| Feb 2, 2024 | MNKTQ Mallinckrodt plc | AGrant or award Restricted Stock Unitsderivative | -20,517 | $0.00 | $0 | 20,517 | Feb 6, 2024 |
| Nov 14, 2023 | MNKTQ Mallinckrodt plc | DDisposition to issuer Ordinary Shares | -96,660 | $0.00 | $0 | 0 | Nov 16, 2023 |
Questions about Bryan M. Reasons
Answered from the filings on this page, as of the latest one.
Is Bryan M. Reasons buying or selling?
Bryan M. Reasons has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Bryan M. Reasons's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Bryan M. Reasons has 0.
Where does Bryan M. Reasons file Form 4?
Bryan M. Reasons has filed Form 4 at ACRS (Aclaris Therapeutics, Inc.); MNKTQ (Mallinckrodt plc) as EVP & CFO; SCTL (Societal CDMO, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.